Status:
COMPLETED
Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Head and Neck Cancers Patients
Eligibility:
All Genders
20+ years
Brief Summary
The purpose of the study is to investigate the clinical usefulness of serum levels of immunologic profiles including pro/anti-inflammatory interleukins, other detectable serum biomarkers including tra...
Eligibility Criteria
Inclusion
- Patients with head and neck cancer receiving curative radiotherapy in NTUH radiation therapy department.
Exclusion
- Patients with head and neck cancer NOT receiving curative radiotherapy in NTUH radiation therapy department.
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03325036
Start Date
July 1 2017
End Date
December 30 2024
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan